A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors
Multiple Cancer Types
The purpose of this study is to evaluate the safety and tolerability of AB521 when taken
alone in participants with advanced solid tumor malignancies and clear cell renal cell
carcinoma (ccRCC).
alone in participants with advanced solid tumor malignancies and clear cell renal cell
carcinoma (ccRCC).
Kidney (Renal Cell),
Phase I
I
Rini, Brian
NCT05536141
VICC-DTURO23168P
Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)
Kidney (Renal Cell)
Kidney (Renal Cell)
Kidney (Renal Cell)
III
Benedetti, Daniel
NCT06401330
COGAREN2231
